# Umbilical Cord Blood Cell (MC001) Transplant Into Injured Spinal Cord Followed by the Locomotor Training

> **NCT03979742** · PHASE2 · TERMINATED · sponsor: **StemCyte, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Spinal Cord Injuries

## Interventions

- **BIOLOGICAL:** Umbilical Cord Blood Mononuclear Cell
- **OTHER:** Locomotor Training

## Key facts

- **NCT ID:** NCT03979742
- **Lead sponsor:** StemCyte, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-02-22
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** business strategic consideration
- **Last updated:** 2025-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03979742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03979742, "Umbilical Cord Blood Cell (MC001) Transplant Into Injured Spinal Cord Followed by the Locomotor Training". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03979742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*